🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07625826
Starting soon Not applicable

The Effect of Esketamine on Cough Reflex During Tracheal Extubation in Patients Undergoing Open Thyroid Surgery

NCT07625826 · tracked via the Priya Life Science China tracker
Sponsor
The Second Hospital of Anhui Medical University
Phase
Not applicable
Started
2026-06
Last updated
2026-06-04

Condition(s) studied

ThyroidectomyCoughing Reflex

Investigational drug(s) / intervention(s)

EsketamineNormal Saline

Esketamine: After anesthesia induction, continue to administer esketamine by infusion at 0.1 mg/kg/h during the maintenance phase of anesthesia, and stop the infusion of esketamine during suturing.

Normal Saline: After anesthetic induction, an equal amount of saline is continuously infused by pump during the maintenance phase of anesthesia, and the saline infusion is stopped during suturing;

Study summary

This study intends to conduct a prospective randomized controlled trial to implement esketamine-assisted anesthesia in patients undergoing open thyroidectomy, in order to observe the effect of esketamine on coughing during extubation in thyroidectomy patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Patients scheduled for elective open thyroid surgery * ASA class I-II * Voluntarily participate in the study and sign the informed consent form Exclusion Criteria: * Body Mass Index \> 30 kg/m² * Patients with unstable ischemic cardiomyopathy, pulmonary hypertension, poorly controlled or untreated hypertension (arterial hypertension, resting systolic/diastolic blood pressure \>180/100 mmHg) * Hepatic or renal dysfunction * History of oral, maxillofacial, neck, or airway surgery, or pathological structural alterations * Respiratory diseases (COPD, asthma, inflammation, chronic cough) * Patients with elevated intracranial pressure * Patients undergoing repeat surgery * History of allergy to the investigational drug used in the study * Patients with psychiatric disorders or alcohol abuse (daily ethanol intake ≥40 g, or having experienced alcohol withdrawal within the past 6 months, or unable to control alcohol consumption)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Second Affiliated Hospital of Anhui Medical University Hefei Anhui

More The Second Hospital of Anhui Medical University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07625826 on ClinicalTrials.gov ↗ ← All trials in China